Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,640Revenue $M1,173Net Margin (%)5.0Z-Score4.3
Enterprise Value $M11,299EPS $0.9Operating Margin %16.7F-Score6
P/E(ttm))265Cash Flow Per Share $3.6Pre-tax Margin (%)12.9Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %0Quick Ratio4.6Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %48.7Current Ratio4.7Lower Leverage y-yN
Price/Cash Flow14.2y-y EBITDA Growth Rate %-29.0ROA % (ttm)1.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.6ROI % (ttm)19.6Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZNWQ Managers 2014-12-31 Reduce-0.13%$142.72 - $183.03
($166.14)
$ 175.425%Reduce -53.29%64,783
JAZZSteve Mandel 2014-09-30 Reduce-0.17%$132.55 - $174.37
($153.67)
$ 175.4212%Reduce -14.30%1,788,607
JAZZNWQ Managers 2014-09-30 Reduce-0.1%$132.55 - $174.37
($153.67)
$ 175.4212%Reduce -32.97%138,705
JAZZSteve Mandel 2014-06-30 Reduce-0.15%$124.63 - $154.82
($138.55)
$ 175.4221%Reduce -10.98%2,087,127
JAZZJoel Greenblatt 2014-06-30 Sold Out -0.02%$124.63 - $154.82
($138.55)
$ 175.4221%Sold Out0
JAZZSteve Mandel 2014-03-31 Buy 1.4%$125.51 - $174.98
($149.95)
$ 175.4215%New holding2,344,486
JAZZNWQ Managers 2014-03-31 Add0.04%$125.51 - $174.98
($149.95)
$ 175.4215%Add 26.81%173,919
JAZZJoel Greenblatt 2014-03-31 Buy 0.02%$125.51 - $174.98
($149.95)
$ 175.4215%New holding7,367
JAZZNWQ Managers 2013-12-31 Reduce-0.05%$82.62 - $126.79
($103.31)
$ 175.4241%Reduce -29.02%137,154
JAZZJohn Paulson 2013-12-31 Sold Out -0.57%$82.62 - $126.79
($103.31)
$ 175.4241%Sold Out0
JAZZNWQ Managers 2013-06-30 Buy 0.12%$52.79 - $70.86
($61.12)
$ 175.4265%New holding198,679
JAZZJohn Paulson 2012-09-30 Buy 0.47%$44.4 - $58.5
($48.28)
$ 175.4272%New holding1,000,000
JAZZKen Heebner 2011-12-31 Sold Out -0.09%$34.8 - $44.27
($38.53)
$ 175.4278%Sold Out0
JAZZKen Heebner 2011-09-30 Buy 0.09%$32.7 - $46.8
($39.51)
$ 175.4277%New holding95,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mulligan SeamusDirector 2015-03-18Sell50,000$185-6.28view
COZADD BRUCE CChairman & CEO 2015-03-10Sell5,000$170.351.78view
Hooper Suzanne SawochkaEVP & General Counsel 2015-03-10Sell1,851$170.361.78view
Cox Russell J.EVP & COO 2015-03-05Sell500$175.1-0.98view
WILSON KAREN JSVP, Finance & PAO 2015-03-03Sell2,598$176.27-1.63view
ENRIGHT PATRICK GDirector 2015-03-02Sell10,000$176-1.48view
Hooper Suzanne SawochkaEVP & General Counsel 2015-02-10Sell1,851$166.93.89view
ENRIGHT PATRICK GDirector 2015-02-10Sell10,000$166.853.92view
Tobias Jeffrey KEVP, R&D & CMO 2015-02-10Sell5,000$166.823.94view
COZADD BRUCE CChairman & CEO 2015-02-10Sell5,000$166.93.89view

Press Releases about JAZZ :

    Quarterly/Annual Reports about JAZZ:

    News about JAZZ:

    Articles On GuruFocus.com
    Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
    Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
    Growth Momentum Should Continue For This Pharmaceutical Company Nov 16 2014 
    Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
    Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 
    comment on JAZZ Mar 22 2013 
    optimized portfolio Jul 27 2011 
    Jazz Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 

    More From Other Websites
    JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Mar 23 2015
    Oppenheimer: Bullish Technical Analysis Of 5 Healthcare Names Mar 18 2015
    This Drugmaker Stock Is Attempting A Re-Breakout Mar 18 2015
    Jazz Pharmaceuticals Up on U.S. Approval of Xyrem REMS - Analyst Blog Mar 04 2015
    Nasdaq 5000 built on biotech this time Mar 03 2015
    4 Big-Volume Stocks to Trade for Breakouts: La Jolla Pharma and More Mar 02 2015
    JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Mar 02 2015
    Splunk Shoots Up After Hours; Monster Beverage Also Up Feb 26 2015
    Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point Feb 26 2015
    Company News for February 26, 2015 - Corporate Summary Feb 26 2015
    Heavy News Day For Several Biotech Stocks Feb 25 2015
    8 Stories JP Morgan Is Watching Today Feb 25 2015
    Jazz Pharmaceuticals (JAZZ) Earnings Report: Q4 2014 Conference Call Transcript Feb 25 2015
    Jazz Pharmaceuticals Tops Q4 Earnings, Provides Guidance - Analyst Blog Feb 25 2015
    Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2014 Financial Results Feb 24 2015
    Jazz Pharmaceuticals Sinks On Outlook, Halt In Drug Trial Feb 24 2015
    Jazz tops Street 4Q forecasts Feb 24 2015
    Jazz tops Street 4Q forecasts Feb 24 2015
    Jazz Pharma Tops, But Stock Falls On Guidance Feb 24 2015
    Hewlett-Packard, Jazz Pharmaceuticals Fall After-Hours Feb 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK